-
Notifications
You must be signed in to change notification settings - Fork 8
/
description.data
8949 lines (8949 loc) · 130 KB
/
description.data
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
(dp0
S'rs2710117(A;A)'
p1
S'higher risk of speech development delay and/or impairment'
p2
sS'rs2834167(A;A)'
p3
S'2.67x increased risk for systemic sclerosis'
p4
sS'rs420259(C;T)'
p5
S'2x risk'
p6
sS'rs2837960(T;T)'
p7
S'normal'
p8
sS'rs2273697(G;G)'
p9
S'normal/common'
p10
sS'rs2230288(A;A)'
p11
S'Homozygous for E326K variant of GBA gene'
p12
sS'rs2395029(G;T)'
p13
S'HLA-B*5701 carrier'
p14
sS'rs683395(C;C)'
p15
S'1.3x risk'
p16
sS'rs3095870(A;A)'
p17
S'normal risk'
p18
sS'rs10192566(G;G)'
p19
S'if diabetic, better response to rosiglitazone'
p20
sS'rs4779584(C;T)'
p21
S'1.23x risk for colorectal cancer'
p22
sS'rs2072797(C;T)'
p23
S'1.5x increased risk of Non-Hodgkin Lymphoma'
p24
sS'rs9960767(A;C)'
p25
S'1.2x increased risk for schizophrenia'
p26
sS'rs2228063(A;G)'
p27
S'None'
p28
sS'rs35600288(AT;AT)'
p29
S'normal risk'
p30
sS'rs6413438(C;C)'
p31
S'normal'
p32
sS'rs55640102(A;C)'
p33
S'carrier of one CYP2C19*12 allele'
p34
sS'rs7997012(G;G)'
p35
S'~18% less likely to respond to citalopram'
p36
sS'rs10239794(T;T)'
p37
S'>1.3x risk for ALS'
p38
sS'rs28694718(A;G)'
p39
S'2x risk'
p40
sS'rs5558(T;T)'
p41
S'normal'
p42
sS'rs20417(C;C)'
p43
S'normal risk of diabetes'
p44
sS'rs6682654(A;G)'
p45
S'1.34x increased risk for rheumatoid arthritis'
p46
sS'rs28399424(T;T)'
p47
S'CYP1A2*6 homozygote'
p48
sS'rs56324128(C;T)'
p49
S'carrier of one CYP3A4*7 allele'
p50
sS'rs4833103(C;C)'
p51
S"0.74x decreased risk for Non-hodgkin's lymphoma"
p52
sS'rs4894(C;C)'
p53
S'1.78x increased risk for schizophrenia in males'
p54
sS'rs12970134(A;A)'
p55
S'adult waist 1.8cm larger on average'
p56
sS'rs28371686(G;G)'
p57
S'CYP2C9*5 homozygote'
p58
sS'rs889312(A;C)'
p59
S'Very slightly higher risk for breast cancer'
p60
sS'rs7900194(A;A)'
p61
S'CYP2C9*8 homozygote'
p62
sS'rs12720461(C;T)'
p63
S'carrier of one CYP1A2*1K_-729C>T allele'
p64
sS'rs1800795(C;G)'
p65
S'complex; see details'
p66
sS'rs17822931(C;C)'
p67
S'wet earwax'
p68
sS'rs28371759(T;T)'
p69
S'normal'
p70
sS'rs2230500(A;G)'
p71
S'1.4x increased risk for stroke'
p72
sS'rs1057868(C;T)'
p73
S'normal'
p74
sS'rs4968451(A;A)'
p75
S'1.5x increased risk for meningioma'
p76
sS'rs1799732(-;-)'
p77
S'less favorable clinical outcome when on antipsychotics'
p78
sS'rs12979860(C;C)'
p79
S'~80% of such hepatitis C patients respond to treatment'
p80
sS'rs7539542(G;G)'
p81
S'normal'
p82
sS'rs2200733(C;C)'
p83
S'normal'
p84
sS'rs198358(A;A)'
p85
S'normal'
p86
sS'rs1953126(C;T)'
p87
S'1.3x increased risk for rheumatoid arthritis'
p88
sS'rs9332131(A;A)'
p89
S'normal'
p90
sS'rs762551(C;C)'
p91
S'CYP1A2 slow metabolizer'
p92
sS'rs28928894(T;T)'
p93
S'normal'
p94
sS'rs992037(C;C)'
p95
S'lowest lysine values'
p96
sS'rs34139813(C;C)'
p97
S'Normal hemoglobin'
p98
sS'rs10492519(A;G)'
p99
S'somewhat higher risk for prostate cancer'
p100
sS'rs1800860(A;A)'
p101
S'10% smaller kidneys as newborns'
p102
sS'rs915909(T;T)'
p103
S'CYP2E1_6498C>T(I321I) homozygote'
p104
sS'rs2075650(A;A)'
p105
S'normal'
p106
sS'rs6267(G;G)'
p107
S'common'
p108
sS'rs4792311(A;A)'
p109
S'increased risk of prostate cancer'
p110
sS'rs1867277(G;G)'
p111
S'normal'
p112
sS'rs2420946(T;T)'
p113
S'1.64x risk for breast cancer'
p114
sS'rs6680578(A;T)'
p115
S'1.11x risk'
p116
sS'rs187238(C;C)'
p117
S'hypertension not a risk factor for sudden cardiac death'
p118
sS'rs11523871(A;A)'
p119
S'normal'
p120
sS'rs57424749(G;G)'
p121
S'normal'
p122
sS'rs27388(A;G)'
p123
S'somewhat increased risk for schizophrenia'
p124
sS'rs743777(A;A)'
p125
S'1.7x risk'
p126
sS'rs2981745(T;T)'
p127
S'>1.6x increased risk for breast cancer in females over 60'
p128
sS'rs1571801(A;A)'
p129
S'>1.36x risk for prostate cancer'
p130
sS'rs3918242(T;T)'
p131
S'1.33x increased risk for MI; also check haplotype'
p132
sS'rs12721634(T;T)'
p133
S'normal'
p134
sS'rs2074190(C;T)'
p135
S'2.2x risk for AIA'
p136
sS'rs619203(G;G)'
p137
S'None'
p138
sS'rs10264272(T;T)'
p139
S'CYP3A5*6 homozygote; nonexpressor for CYP3A5'
p140
sS'rs2740574(G;G)'
p141
S'2.5x increased risk for prostate or ovarian cancer; CYP3A4*1B homozygote'
p142
sS'rs6413420(G;T)'
p143
S'carrier of one CYP2E1*7_-71G>T allele'
p144
sS'rs55752064(T;T)'
p145
S'normal'
p146
sS'rs1801252(G;G)'
p147
S''
p148
sS'rs1076560(A;C)'
p149
S'1.3x increased risk for alcoholism'
p150
sS'rs1801274(C;C)'
p151
S'normal'
p152
sS'rs72558190(A;C)'
p153
S'carrier of one CYP2C9*15 allele'
p154
sS'rs419598(C;T)'
p155
S'0.29x lower risk for periodontitis'
p156
sS'rs3802177(C;C)'
p157
S'1.16x increased risk for type-2 diabetes'
p158
sS'rs10830963(G;G)'
p159
S'increased type-2 diabetes risk'
p160
sS'rs3817964(A;T)'
p161
S'possibly at 4x higher risk of [[rheumatoid arthritis]]'
p162
sS'rs7997012(A;A)'
p163
S'~18% more likely to respond to citalopram'
p164
sS'rs56411402(C;C)'
p165
S'CYP3A5*4 homozygote; nonexpressor for CYP3A5'
p166
sS'rs55951658(C;C)'
p167
S'CYP3A4*4 homozygote'
p168
sS'rs3774426(T;T)'
p169
S'normal'
p170
sS'rs1922892(T;T)'
p171
S'higher risk of speech development delay and/or impairment'
p172
sS'rs2241766(T;T)'
p173
S'normal'
p174
sS'rs6503691(C;T)'
p175
S'None'
p176
sS'rs3814113(C;C)'
p177
S'0.8x decreased risk for ovarian cancer'
p178
sS'rs4994(C;T)'
p179
S'2x higher risk in certain women for cardiac events'
p180
sS'rs7536563(A;G)'
p181
S'1.12x risk'
p182
sS'rs1131532(C;C)'
p183
S'normal'
p184
sS'rs2448490(A;A)'
p185
S'0.57x (reduced) risk for metastasis in LN-/ER+ breast cancer patients'
p186
sS'rs72552791(G;G)'
p187
S'CYP3A5*11 homozygote; nonexpressor for CYP3A5'
p188
sS'rs1554483(G;G)'
p189
S'1.8x higher risk for obesity if in haplotype'
p190
sS'rs27388(G;G)'
p191
S'normal risk'
p192
sS'rs793862(A;A)'
p193
S'3-5x dyslexia risk'
p194
sS'rs13149290(T;T)'
p195
S'normal risk'
p196
sS'rs2278206(C;C)'
p197
S'1.16x increased risk for asthma'
p198
sS'rs11162922(G;G)'
p199
S'normal'
p200
sS'rs2074190(T;T)'
p201
S'common'
p202
sS'rs2108622(T;T)'
p203
S'higher warfarin dosing'
p204
sS'rs1800562(G;G)'
p205
S'Not a C282Y hemochromatosis carrier.'
p206
sS'rs1136410(T;T)'
p207
S'normal'
p208
sS'rs5882(A;G)'
p209
S"lower risk of dementia and Alzheimer's disease"
p210
sS'rs2066702(C;C)'
p211
S'common'
p212
sS'rs2070673(A;T)'
p213
S'carrier of one CYP2E1*7_-333T>A allele'
p214
sS'rs28399424(C;C)'
p215
S'normal'
p216
sS'rs2515475(C;T)'
p217
S'1.27x increased ARDS risk in critically ill patients'
p218
sS'rs10246256(T;T)'
p219
S'higher risk of speech development delay and/or impairment'
p220
sS'rs4794067(C;T)'
p221
S'2.1x risk for AIA'
p222
sS'rs10033464(G;G)'
p223
S'normal'
p224
sS'rs312481(C;T)'
p225
S'normal'
p226
sS'rs10918594(C;C)'
p227
S'Shorter QT interval'
p228
sS'rs13376333(C;T)'
p229
S'1.5x higher risk of atrial fibrillation'
p230
sS'rs910873(A;G)'
p231
S'1.7x increased risk of melanoma'
p232
sS'rs521102(C;C)'
p233
S'normal'
p234
sS'rs2670660(G;G)'
p235
S'2.74x'
p236
sS'rs3184504(C;T)'
p237
S'increased risk for celiac disease'
p238
sS'rs527974(C;T)'
p239
S'better response to certain calcium channel blockers'
p240
sS'rs12567232(A;A)'
p241
S"Increased risk for Crohn's Disease"
p242
sS'rs1570360(A;G)'
p243
S'3x risk'
p244
sS'rs17482753(G;T)'
p245
S'elevated triglycerides'
p246
sS'rs6897932(C;T)'
p247
S'1.3x increased risk for multiple sclerosis'
p248
sS'rs58597806(T;T)'
p249
S'likely reduced UGT1A9 glucuronidation'
p250
sS'rs12255372(T;T)'
p251
S'increased breast cancer, type-2 diabetes, and aggressive prostate cancer risk'
p252
sS'rs10513025(T;T)'
p253
S'normal'
p254
sS'rs28928894(C;C)'
p255
S'homozygote for pachyonychia congenita Type I mutation'
p256
sS'rs11523871(C;C)'
p257
S'>1.6x increased breast cancer risk for women over 60'
p258
sS'rs17244841(A;A)'
p259
S'more responsive to statin treatment'
p260
sS'rs4986790(G;G)'
p261
S'complex; numerous associations reported'
p262
sS'rs1892534(G;G)'
p263
S'normal'
p264
sS'rs41279857(T;T)'
p265
S'CYP3A5*S100Y homozygote; nonexpressor for CYP3A5'
p266
sS'rs1328674(G;G)'
p267
S'average'
p268
sS'rs28940574(A;A)'
p269
S'Canavan disease'
p270
sS'rs2108622(C;C)'
p271
S'lower warfarin dosing'
p272
sS'rs599839(A;G)'
p273
S'1.29x increased risk for heart disease'
p274
sS'rs12304921(A;G)'
p275
S'2.5x risk'
p276
sS'rs1676486(A;A)'
p277
S'>1.4x risk for LDH'
p278
sS'rs4648317(C;T)'
p279
S'prone to higher nicotine dependence?'
p280
sS'rs55897648(A;A)'
p281
S'CYP2E1*3 homozygote'
p282
sS'rs1800709(C;C)'
p283
S'normal'
p284
sS'rs10498345(A;A)'
p285
S'<0.5x decreased risk for coronary spasm'
p286
sS'rs1501299(C;C)'
p287
S'1.8x higher breast cancer risk'
p288
sS'rs25532(C;T)'
p289
S'may be part of a haplotype associated with OCD'
p290
sS'rs10264272(C;C)'
p291
S'normal'
p292
sS'rs17238540(T;T)'
p293
S'common'
p294
sS'rs2297480(A;C)'
p295
S'normal'
p296
sS'rs800292(C;T)'
p297
S'increased risk of macular degeneration'
p298
sS'rs17376328(A;A)'
p299
S'lower blood pressure'
p300
sS'rs198358(G;G)'
p301
S'lower blood pressure'
p302
sS'rs1801282(G;G)'
p303
S'watch out for high fat in diet'
p304
sS'rs8192466(C;T)'
p305
S'None'
p306
sS'rs663048(T;T)'
p307
S'3x risk of with [[lung cancer]]'
p308
sS'rs4464148(C;C)'
p309
S'1.35x increased risk for colorectal cancer'
p310
sS'rs851715(G;G)'
p311
S'None'
p312
sS'rs669(G;G)'
p313
S'3.8x or higher increased risk for Alzheimers'
p314
sS'rs3783799(A;A)'
p315
S'1.4x increased risk for stroke'
p316
sS'rs4363657(T;T)'
p317
S'normal'
p318
sS'rs9332239(C;C)'
p319
S'normal'
p320
sS'rs12469063(A;A)'
p321
S'>1.7x risk for restless legs'
p322
sS'rs1042522(C;C)'
p323
S'longer lifespan?'
p324
sS'rs34516635(A;A)'
p325
S'longevity effect?'
p326
sS'rs3923809(G;G)'
p327
S'common'
p328
sS'rs1801278(A;G)'
p329
S'reduced colorectal risk when combined with INSR SNP'
p330
sS'rs5770917(T;T)'
p331
S'normal'
p332
sS'rs1042838(G;G)'
p333
S'normal risk'
p334
sS'rs12021720(T;T)'
p335
S'rare genotype but harmless'
p336
sS'rs56324128(T;T)'
p337
S'CYP3A4*7 homozygote'
p338
sS'rs1801278(G;G)'
p339
S'normal'
p340
sS'rs27072(C;C)'
p341
S'2x risk of severe alcohol withdrawal'
p342
sS'rs1954787(T;T)'
p343
S'~10% less likely to respond to citalopram'
p344
sS'rs4290(C;T)'
p345
S'higher cardiovascular risk in African Americans'
p346
sS'rs2143340(T;T)'
p347
S'common'
p348
sS'rs56276455(G;G)'
p349
S'normal'
p350
sS'rs2820037(A;T)'
p351
S'1.5x risk'
p352
sS'rs1867277(A;G)'
p353
S'1.5x increased risk for thyroid cancer'
p354
sS'rs1799971(A;G)'
p355
S'stronger cravings for alcohol. if alcoholic, naltrexone treatment 2x more successful'
p356
sS'rs11045585(A;A)'
p357
S'24% chance (lower than average) of docetaxel-induced leukopenia/neutropenia'
p358
sS'rs1799999(T;T)'
p359
S'insulin resistance'
p360
sS'rs2305480(C;C)'
p361
S'normal'
p362
sS'rs1057868(T;T)'
p363
S'1.6x higher overall CYP3A activity'
p364
sS'rs6910071(G;G)'
p365
S'6x higher risk of [[rheumatoid arthritis]]'
p366
sS'rs10801935(C;C)'
p367
S'0.3x decreased risk of breast cancer'
p368
sS'rs10495584(G;G)'
p369
S'lower blood pressure'
p370
sS'rs4149274(C;T)'
p371
S'associated with higher HDL cholesterol'
p372
sS'rs908832(A;A)'
p373
S'3.8x increased risk for early-onset Alzheimers'
p374
sS'rs16901979(A;C)'
p375
S'1.5x increased risk for prostate cancer'
p376
sS'rs4986790(A;A)'
p377
S'normal'
p378
sS'rs10468017(T;T)'
p379
S'associated with higher HDL cholesterol'
p380
sS'rs17001266(-;-)'
p381
S'1.58x increased risk for schizophrenia in males'
p382
sS'rs1328674(A;A)'
p383
S'higher risk for RA'
p384
sS'rs1800587(C;T)'
p385
S'normal'
p386
sS'rs72547517(G;G)'
p387
S'normal'
p388
sS'rs5065(A;G)'
p389
S'normal risk'
p390
sS'rs8179183(C;C)'
p391
S'normal'
p392
sS'rs5496(G;G)'
p393
S'common for caucasians, despite hapmap'
p394
sS'rs2837960(G;T)'
p395
S'normal'
p396
sS'rs7639618(C;C)'
p397
S'normal'
p398
sS'rs17878459(C;C)'
p399
S'CYP2C19*2B homozygote'
p400
sS'rs9642880(T;T)'
p401
S'1.5x increased bladder cancer risk'
p402
sS'rs3923809(A;G)'
p403
S'1.9x risk for restless legs'
p404
sS'rs5065(G;G)'
p405
S'0.87x risk on diuretic; if hypertensive, better outcome when treated with diuretic than with calcium channel blocker'
p406
sS'rs4076128(G;G)'
p407
S'normal'
p408
sS'rs1726866(C;C)'
p409
S'can taste bitter'
p410
sS'rs11162922(A;G)'
p411
S'1.3x risk'
p412
sS'rs9550642(A;G)'
p413
S'1.3x risk'
p414
sS'rs13357391(T;T)'
p415
S'normal'
p416
sS'rs6498169(G;G)'
p417
S'common'
p418
sS'rs144848(G;G)'
p419
S'1.3x increased risk for breast cancer'
p420
sS'rs1495965(A;G)'
p421
S'1.2x higher risk for spondylitis'
p422
sS'rs683395(T;T)'
p423
S'normal'
p424
sS'rs10134944(T;T)'
p425
S'1.3x risk'
p426
sS'rs9886784(A;A)'
p427
S'>3.2x risk for AD'
p428
sS'rs10455872(A;G)'
p429
S'increased Coronary Heart disease risk'
p430
sS'rs34815109(-;-)'
p431
S'normal'
p432
sS'rs55752064(C;T)'
p433
S'carrier of one CYP2C19*14 allele'
p434
sS'rs2070744(C;C)'
p435
S'increased prostate cancer risk'
p436
sS'rs72547517(A;G)'
p437
S'carrier of one CYP1A2*8 allele'
p438
sS'rs10754339(G;G)'
p439
S'1.45x increased risk of breast cancer'
p440
sS'rs705381(C;C)'
p441
S'normal'
p442
sS'rs1793004(G;G)'
p443
S"0.89x decreased risk for Crohn's disease"
p444
sS'rs28371706(C;C)'
p445
S'normal'
p446
sS'rs7213516(A;A)'
p447
S'higher cardiovascular risk in African Americans'
p448
sS'rs4778241(A;C)'
p449
S'usually brown eye color'
p450
sS'rs872071(G;G)'
p451
S'~1.5x increased risk for chronic lymphocytic leukemia'
p452
sS'rs7014851(T;T)'
p453
S'common'
p454
sS'rs10485057(A;G)'
p455
S'normal?'
p456
sS'rs7757037(A;A)'
p457
S'0.63x decreased risk for bipolar disorder'
p458
sS'rs4775041(G;G)'
p459
S'highest phosphatidylethanolamine values'
p460
sS'rs1052133(C;C)'
p461
S'normal'
p462
sS'rs1570360(G;G)'
p463
S'normal'
p464
sS'rs55951658(C;T)'
p465
S'carrier of one CYP3A4*4 allele'
p466
sS'rs8028689(C;T)'
p467
S'usually brown eye color'
p468
sS'rs2308327(G;G)'
p469
S'0.10x decreased risk for lung cancer'
p470
sS'rs1800454(A;A)'
p471
S'affected'
p472
sS'rs10871777(G;G)'
p473
S'normal'
p474
sS'rs6675281(C;C)'
p475
S'common'
p476
sS'rs34983651(AT;AT)'
p477
S'normal risk'
p478
sS'rs3817964(T;T)'
p479
S'6x higher risk of [[rheumatoid arthritis]]'
p480
sS'rs10871777(A;G)'
p481
S'adults likely to be 0.22 BMI units higher'
p482
sS'rs2231142(A;C)'
p483
S'1.74x increased gout risk; gefinitib takers 4x more susceptible to diarrhea'
p484
sS'rs1057911(A;A)'
p485
S'CYP2C9_50298A>T homozygote'
p486
sS'rs9332739(G;G)'
p487
S'normal'
p488
sS'rs5275(T;T)'
p489
S'normal'
p490
sS'rs9332130(A;G)'
p491
S'carrier of one CYP2C9*10 allele'
p492
sS'rs17234657(G;G)'
p493
S'2.3x risk'
p494
sS'rs1154155(T;T)'
p495
S'normal'
p496
sS'rs725613(A;A)'
p497
S'1.2x increased type-1 diabetes risk; 1.2x increased multiple sclerosis risk'
p498
sS'rs12487066(C;T)'
p499
S'1.09x increased risk for multiple sclerosis'